(Corrects headline to say co gets EMA acceptance for review, not that company is to be reviewed by EMA)
July 18 (Reuters) - Merck (NYSE:MRK) KGaA MRCG.DE :
* Merck KGaA, Darmstadt, Germany receives European Medicines Agency (EMA) acceptance for review of marketing authorization application for Cladribine tablets Source text for Eikon: Further company coverage: MRCG.DE
(Bengaluru Newsroom : +1-646-223-8780)